Elevated plasma amyloid β-peptide 1–42 and onset of dementia in adults with Down syndrome

This publication has 19 references indexed in Scilit:

• Plasma amyloid ?-peptide 1-42 and incipient Alzheimer's disease
  Annals of Neurology, 1999
• The beta APP717 Alzheimer mutation increases the percentage of plasma amyloid-beta protein ending at A beta 42(43)
  Neurology, 1997
• Aβ1–40 but not Aβ1–42 levels in cortex correlate with apolipoprotein E ϵ4 allele dosage in sporadic Alzheimer's disease
  Brain Research, 1997
• Amyloid β protein (Aβ) deposition in chromosome 14–linked Alzheimer's disease: Predominance of Aβ₄₂₍₄₃₎
  Annals of Neurology, 1996
• Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation
  Neurobiology of Disease, 1996
• Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome).
  Proceedings of the National Academy of Sciences, 1995
• Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome
  Annals of Neurology, 1995
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
  Nature, 1994
• Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
  Neuron, 1994
• The apolipoprotein ε4 allele in patients with Alzheimer's disease
  Annals of Neurology, 1993